Scher, H. I., Halabi, S., Tannock, I. F., Morris, M., Sternberg, C. N., Carducci, M. A., … Hussain, M. (2008). In reply. Journal of Clinical Oncology, 26(21), 3648–3649. https://doi.org/10.1200/JCO.2008.17.2494

Scher, H. I., S. Halabi, I. F. Tannock, M. Morris, C. N. Sternberg, M. A. Carducci, M. A. Eisenberger, et al. “In reply.” Journal of Clinical Oncology 26, no. 21 (September 15, 2008): 3648–49. https://doi.org/10.1200/JCO.2008.17.2494.

Scher HI, Halabi S, Tannock IF, Morris M, Sternberg CN, Carducci MA, et al. In reply. Journal of Clinical Oncology. 2008 Sep 15;26(21):3648–9.

Scher, H. I., et al. “In reply.” Journal of Clinical Oncology, vol. 26, no. 21, Sept. 2008, pp. 3648–49. Scopus, doi:10.1200/JCO.2008.17.2494.

Scher HI, Halabi S, Tannock IF, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak DP, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M. In reply. Journal of Clinical Oncology. 2008 Sep 15;26(21):3648–3649.